Hercules Capital Current Ratio 2010-2023 | HTGC
Hercules Capital current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Hercules Capital Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-12-31 |
$0.15B |
$0.05B |
2.75 |
| 2023-09-30 |
$0.07B |
$0.05B |
1.50 |
| 2023-06-30 |
$0.11B |
$0.05B |
2.28 |
| 2023-03-31 |
$0.11B |
$0.03B |
3.31 |
| 2022-12-31 |
$0.06B |
$0.05B |
1.21 |
| 2022-09-30 |
$0.09B |
$0.03B |
2.64 |
| 2022-06-30 |
$0.14B |
$0.04B |
3.84 |
| 2022-03-31 |
$0.08B |
$0.03B |
3.02 |
| 2021-12-31 |
$0.15B |
$0.05B |
3.22 |
| 2021-09-30 |
$0.27B |
$0.04B |
7.20 |
| 2021-06-30 |
$0.04B |
$0.04B |
1.17 |
| 2021-03-31 |
$0.11B |
$0.03B |
3.80 |
| 2020-12-31 |
$0.26B |
$0.04B |
7.06 |
| 2020-09-30 |
$0.07B |
$0.03B |
2.35 |
| 2020-06-30 |
$0.09B |
$0.03B |
3.05 |
| 2020-03-31 |
$0.08B |
$0.03B |
2.25 |
| 2019-12-31 |
$0.14B |
$0.03B |
4.46 |
| 2019-09-30 |
$0.06B |
$0.04B |
1.49 |
| 2019-06-30 |
$0.05B |
$0.04B |
1.31 |
| 2019-03-31 |
$0.05B |
$0.03B |
1.66 |
| 2018-12-31 |
$0.06B |
$0.03B |
2.42 |
| 2018-09-30 |
$0.06B |
$0.02B |
2.86 |
| 2018-06-30 |
$0.09B |
$0.03B |
3.57 |
| 2018-03-31 |
$0.13B |
$0.02B |
7.08 |
| 2017-12-31 |
$0.11B |
$0.03B |
3.99 |
| 2017-09-30 |
$0.16B |
$0.02B |
8.34 |
| 2017-06-30 |
$0.19B |
$0.02B |
8.46 |
| 2017-03-31 |
$0.17B |
$0.02B |
10.45 |
| 2016-12-31 |
$0.03B |
$0.02B |
1.54 |
| 2016-09-30 |
$0.09B |
$0.02B |
5.34 |
| 2016-06-30 |
$0.07B |
$0.02B |
4.36 |
| 2016-03-31 |
$0.03B |
$0.01B |
2.33 |
| 2015-12-31 |
$0.11B |
$0.02B |
6.59 |
| 2015-09-30 |
$0.16B |
$0.02B |
8.22 |
| 2015-06-30 |
$0.14B |
$0.01B |
10.56 |
| 2015-03-31 |
$0.20B |
$0.01B |
21.76 |
| 2014-12-31 |
$0.25B |
$0.01B |
17.68 |
| 2014-09-30 |
$0.17B |
$0.01B |
14.63 |
| 2014-06-30 |
$0.13B |
$0.01B |
12.34 |
| 2014-03-31 |
$0.24B |
$0.01B |
26.50 |
| 2013-12-31 |
$0.28B |
$0.01B |
19.88 |
| 2013-09-30 |
$0.22B |
$0.01B |
15.58 |
| 2013-06-30 |
$0.15B |
$0.01B |
12.79 |
| 2013-03-31 |
$0.22B |
$0.01B |
25.71 |
| 2012-12-31 |
$0.19B |
$0.01B |
16.64 |
| 2012-09-30 |
$0.12B |
$0.01B |
12.10 |
| 2012-06-30 |
$0.06B |
$0.01B |
6.79 |
| 2012-03-31 |
$0.05B |
$0.01B |
8.31 |
| 2011-12-31 |
$0.07B |
$0.01B |
6.50 |
| 2011-09-30 |
$0.10B |
$0.01B |
13.02 |
| 2011-06-30 |
$0.20B |
$0.01B |
23.03 |
| 2011-03-31 |
$0.12B |
$0.01B |
15.94 |
| 2010-12-31 |
$0.11B |
$0.01B |
12.80 |
| 2010-09-30 |
$0.10B |
$0.01B |
16.49 |
| 2010-06-30 |
$0.06B |
$0.01B |
8.34 |
| 2010-03-31 |
$0.12B |
$0.00B |
29.79 |
| 2009-12-31 |
$0.13B |
$0.01B |
10.85 |
| 2009-09-30 |
$0.09B |
$0.01B |
15.11 |
| 2009-06-30 |
$0.05B |
$0.01B |
7.03 |
| 2009-03-31 |
$0.02B |
$0.00B |
3.99 |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Finance - SBIC & Commercial |
$3.094B |
$0.461B |
|
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|
